Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Inmed Pharmaceuticals Inc
(NQ:
INM
)
0.1440
+0.0040 (+2.86%)
Streaming Delayed Price
Updated: 3:25 PM EDT, Aug 19, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
166,999
Open
0.1400
Bid (Size)
0.1434 (2)
Ask (Size)
0.1496 (36)
Prev. Close
0.1400
Today's Range
0.1400 - 0.1497
52wk Range
0.1207 - 2.080
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD
August 16, 2024
Via
Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
August 07, 2024
Via
CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
Performance
YTD
-63.08%
-63.08%
1 Month
-45.60%
-45.60%
3 Month
-55.83%
-55.83%
6 Month
-61.70%
-61.70%
1 Year
-83.26%
-83.26%
More News
Read More
InMed Pharmaceuticals Inc. (NASDAQ: INM) Subsidiary BayMedica Releases Market Report for 2023 on “Minor Cannabinoids”
August 07, 2024
Via
Investor Brand Network
Topics
Cannabis
Exposures
Cannabis
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Long-Term Study Results Confirm Positive Results of Developing Treatment for AD
July 30, 2024
Via
Investor Brand Network
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
July 24, 2024
Via
Investor Brand Network
InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089, a Promising Treatment for Age-Related Macular Degeneration
July 24, 2024
Via
CannabisNewsWire
The Rising Importance Of Minor Cannabinoids In The Growing Edible Market
July 19, 2024
Via
News Direct
Topics
Cannabis
Exposures
Cannabis
BioMedNewsBreaks — InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment
July 11, 2024
Via
Investor Brand Network
7 F-Rated Growth Stocks to Avoid Right Now: June 2024
June 28, 2024
Via
InvestorPlace
InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases
June 14, 2024
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference
June 11, 2024
Via
Investor Brand Network
Why Smartsheet Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
June 06, 2024
Via
Benzinga
Why G-III Apparel Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 06, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
June 06, 2024
Via
InvestorPlace
INM Stock Earnings: InMed Pharmaceuticals Reported Results for Q3 2024
May 14, 2024
Via
InvestorPlace
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q3 Fiscal 2024 Financial Results, Business Update
May 14, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer's – New Studies Showcase INM-901's Therapeutic Abilities
May 07, 2024
Via
News Direct
Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket
May 01, 2024
Via
Benzinga
Why Tesla Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
April 24, 2024
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Welcomes Leading Authority in Alzheimer’s Research to Scientific Advisory Board
April 18, 2024
Via
Investor Brand Network
CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports on Promising Results from Study on INM-089 Treatment of Dry AMD
April 16, 2024
Via
Investor Brand Network
InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Favorable Results from INM-901 Preclinical AD Studies
April 04, 2024
Via
Investor Brand Network
TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension
March 21, 2024
Via
Investor Brand Network
InMed Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
February 23, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Charles & Colvard And 3 Other Stocks Under $2 Insiders Are Buying
February 22, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.